Associate Professor Beale is Director of Cancer Services and Director of Palliative Care, Sydney Local Health District, Head of Medical Oncology Department at Concord Hospital, Senior Staff Specialist at RPA, and at Chris O’Brien Lifehouse and Associate Professor at the University of Sydney. He has a special interest in ovarian, breast, colorectal and upper gastrointestinal cancers and is involved in Phase I, II and III clinical trials for all of these cancers and is the PI in several breast and ovarian cancer trials. He has published more than 100 peer reviewed papers. He is the Chair of ANZGOG and is a member of the AGITG and ANZBCTG trials groups.

Dr Victoria Beshay is the team leader of the Familial Molecular genetics diagnostic laboratory, at the Peter MacCallum Cancer Centre. She leads a team of 20 staff that specialises in identification and curation of cancer predisposition genes. She has completed a PhD at the University of Melbourne and is a member of the Human Genetics Society of Australasia. Victoria has implemented novel tests for the detection of cancer genes, especially those associated with inherited disorders in breast, ovarian, prostate, colorectal, renal and skin cancers, more recently based on multi-gene panels. Victoria has an interest in quality and is regularly involved in accreditation of external laboratories through NATA.

Paul Cohen is a clinician researcher at the Western Australian Gynaecological Cancer Service, King Edward Memorial Hospital, and St John of God Subiaco Hospital in Perth.  He is the current program chair of the ANZGOG Annual Scientific Meeting and a Director of ANZGOG.  He is a member of the Australian eviQ National Guidelines Cancer Genetics Reference Committee, ANZGOG Cervix Tumour Type Working Group, Australian Clinical Trial Alliance Impact and Implementation Committee,  International Gynaecological Cancer Society Education Committee and is a member of the Editorial Board of the International Journal of Gynaecological Cancer.

Paul's research interests include the supportive care of women affected by gynaecological malignancies and patient-report outcomes, cancer genetics, the management of patients with cervical pre-cancer and cancer, the epidemiology of gynaecological malignancies and biomarkers to predict histological tumour regression in women with high-grade serous ovarian cancer following neoadjuvant chemotherapy.

Professor Michael Friedlander AM is conjoint Professor of Medicine at The University of New South Wales and a medical oncologist at the Royal Hospital for Women and The Prince of Wales Hospital in Sydney. After co-founding ANZGOG in 2000, he took up the position of inaugural Chair and served as Chair between the years of 2000-2008, when he took on the role of Director of Research for four years before taking on the Chair of OASIS Steering Committee position, from which he has recently stood down.

Professor Friedlander AM was also President of the International Society of Gynaecological Oncology (IGCS) from 2004-2006 and was closely involved with the Gynaecological Cancer Inter-Group from its inception. He has published over 400 papers including many book chapters and invited reviews. Professor Friedlander AM has received a number of awards including the Medical Oncology Group of Australia Cancer Achievement Award in 2007 recognising his contribution to Cancer Control and Research in Australia, as well as an Order of Australia (AM) in 2011 for service to Medicine in the field of Oncology.

Dr Ganessan Kichenadasse is a medical oncologist and clinical pharmacologist at Flinders Medical Centre and Flinders University. He is the current statewide lead for the South Australian Cancer Clinical Network. His main areas of interest include caring for people with gynaecological, genitourinary and rare cancers. He is also involved in early phase drug development and other phases of clinical trials. He has been an active member of ANZGOG for nearly  decade and currently sits on the ANZGOG Research Advisory Committee and the Uterine Tumour Type Working Group.

Associate Professor Tarek Meniawy is a medical oncologist who subspecialises in melanoma, gynaecological cancers as well as early-phase clinical trials. He is an Adjunct Associate Professor at Edith Cowan University and a Clinical Senior Lecturer at the University of Western Australia, where has was awarded a PhD degree in 2016. He is an active clinical and translational researcher, and is involved in early drug development as a Principal Investigator at Linear Clinical Research, the only dedicated Phase I unit in Western Australia, and one of a handful of such dedicated units in Australia. A/Prof Meniawy is Chair of the ANZGOG Ovarian Tumour Working Group and serves on the Research Advisory Committee and OASIS Steering Committee. He is also a member of the statewide Western Australia Gynaecologic Cancer Service (WAGCS), as well as the WA Kirkbride Melanoma Advisory Service.

Professor Nicklin is a graduate of the University of Queensland.  He did his internship and residency at the Royal Brisbane and Royal Women’s Hospitals.  He subsequently went on to do specialty training in obstetrics and gynaecology in Queensland.  He then did his sub-specialty training in gynaecologic oncology at the Royal Hospital for Women in Sydney and the Ohio State University, USA.  He returned to Queensland and set up practice as a gynaecologic oncologist in late 1995.  He is currently a Professor of Gynaecologic Oncology at University of Qld, Director of Gynaecologic Oncology at RBWH, a past Chairman of Australian Society of Gynaecologic Oncologists (ASGO), a member of ANZGOG, a member of the CGO subspecialty committee of RANZCOG and conducts his private practice at the Wesley Hospital, Brisbane.  He has a particular interest in medical aid work.  He goes to Fiji annually for medical aid work and teaching, and is an International Gynecologic Cancer Society mentor to the area.  

Professor Andreas Obermair is a Brisbane-based, RANZCOG accredited Certified Gynaecological Oncologist (CGO). He is a full Professor at the University of Queensland and leads the Queensland Centre for Gynaecological Cancer (QCGC) Research. He operates his private practice as a Gynaecological Oncologist from his consulting suite at Spring Hill and he regularly visits the Sunshine Coast. He also holds an appointment as a part-time staff specialist at the Royal Brisbane and Women’s Hospital in Brisbane, Queensland. He is a member of ANZGOG and a past Board Director.

Prof Obermair also co-founded the Cherish Women's Cancer Foundation to raise funds for urgently needed research into causes, more effective, kinder and gentler treatments for gynaecological cancer.

Professor Clare Scott is a Medical Oncologist at the Royal Melbourne Hospital and Royal Women’s Hospital and Laboratory Head at the Walter and Eliza Hall Institute of Medical Research, studying drug resistance in ovarian cancer. She has 15 years’ experience in clinical cancer genetics, including working in Familial Cancer Clinics and in treating breast and ovarian cancer. In the lab, she focuses on ovarian biology, including the role of apoptosis in infertility and on developing targeted therapies for ovarian cancer in novel ovarian cancer models. She has been awarded a Clinical Fellowship from the Victorian Cancer Agency (2011) and the Sir Edward Dunlop Cancer Research Fellowship from the Cancer Council Victoria (2012). Professor Scott is a very active member of ANZGOG, she is the current Chair of the ANZGOG OASIS Committee, sits on the ANZGOG Research Advisory Committee, the Ovarian Tumour Type Working Group and the TR-ANZGOG Steering Committee.

Dr Bryony Simcock works as a gynaecological oncologist in Christchurch South Island New Zealand where she has worked for 12 years. Her subspecialty training was undertaken in Melbourne  and Cambridge in the UK. She is involved with a wide range of research interests in gynaecological cancer and precancer. She is an active member of ANZGOG, the ANZGOG ovarian TTWG and ASGO , she also is an examiner for CGO. She is a member of the Editorial Board for the Australian New Zealand Journal of Obstetrics and Gynaecology. She also has a specific interest in medical aid and works regularly in Fiji.